Search results
-
ESMO 2023 – Amgen keeps tarlatamab filing plans under wraps
ESMO 2023 – Amgen keeps tarlatamab filing plans under … DLL3 positivity 40% ORR with 10mg dose (40/100 pts) at ESMO 2023, responses seen regardless of DLL3 expression; …
- 10/21/2023 - 10:50 -
ESMO 2023 – Perla gives Jemperli combos more backing
ESMO 2023 – Perla gives Jemperli combos more backing …
- 10/21/2023 - 11:10 -
After failing to get Seagen Merck turns to Daiichi
… TROP2 4 Tropion-Lung01 & Tropion-Breast01 data at ESMO 2023 Astra paid $1bn up front, $1bn due in …
- 10/21/2023 - 15:55 -
ESMO 2023 – Jiangsu Hengrui sets a low bar in KRAS G12D inhibition
ESMO 2023 – Jiangsu Hengrui sets a low bar in KRAS G12D …
- 10/18/2023 - 16:33 -
ESMO 2023 – duelling PD-1 drugs
ESMO 2023 – duelling PD-1 drugs Quick …
- 10/18/2023 - 15:52 -
ESMO 2023 – tarlatamab hits the target for Amgen
ESMO 2023 – tarlatamab hits the target for Amgen … T-cell engager Ph2 Dellphi-301 3L SCLC (data at ESMO 2023) BI 764532 Boehringer Ingelheim … Ph1 SCLC & neuroendocrine tumours (focus on NETs at ESMO 2023) HPN328 Harpoon Therapeutics …
- 10/18/2023 - 15:54 -
ESMO 2023 – some Tropion fears allayed
ESMO 2023 – some Tropion fears allayed …
- 10/20/2023 - 11:52 -
ESMO 2023 – butterflies for J&J
ESMO 2023 – butterflies for J&J Full …
- 10/20/2023 - 19:13 -
ESMO 2023 – Lumakras still looks like a colorectal also-ran
ESMO 2023 – Lumakras still looks like a colorectal … months 3.9 months 6.9 months N/A Source: ESMO 2023, AACR 2023 & ESMO 2022. …
- 10/19/2023 - 16:05 -
ESMO 2023 – Roche heralds "unprecedented" Alecensa data
ESMO 2023 – Roche heralds "unprecedented" Alecensa data …
- 10/18/2023 - 15:53ApexOnco Editorial Team
